Argenx Se (ARGX) Operating Leases (2019 - 2025)
Argenx Se (ARGX) posted Operating Leases of $36.3 million for Q4 2025, down 6.98% on a QoQ basis from $39.1 million in Q4 2024, and down 6.98% year-over-year from $39.1 million in Q4 2024.
Argenx Se (ARGX) Operating Leases (2019 - 2025) Analysis & Trends
Argenx Se's Operating Leases history runs 7 years deep, the most recent figure standing at $36.3 million for Q4 2025.
- Quarterly Operating Leases fell 6.98% year-over-year to $36.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $36.3 million (down 6.98% YoY) and the FY2025 annual result came in at $36.3 million, down 6.98% from the prior year.
- Operating Leases was $36.3 million for Q4 2025 at Argenx Se, down from $39.1 million in the prior quarter.
- Across five years, Operating Leases topped out at $39.1 million in Q4 2024 and bottomed at $4.4 million in Q2 2021.
- A 5-year average of $18.7 million and a median of $12.2 million in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2021 — Operating Leases fell 13.84% — and 2024, when it jumped 154.35%.
- Argenx Se's Operating Leases stood at $8.0 million in 2021, then climbed by 13.24% to $9.0 million in 2022, then soared by 70.43% to $15.4 million in 2023, then soared by 154.35% to $39.1 million in 2024, then fell by 6.98% to $36.3 million in 2025.
- Business Quant data shows ARGX's Operating Leases at $36.3 million in Q4 2025, $39.1 million in Q4 2024, and $15.4 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36.33 Mn |
| Dec 31, 2024 | 39.05 Mn |
| Dec 31, 2023 | 15.35 Mn |
| Dec 31, 2022 | 9.01 Mn |
| Dec 31, 2021 | 7.96 Mn |
| Jun 30, 2021 | 4.43 Mn |
| Dec 31, 2020 | 6.00 Mn |
| Jun 30, 2020 | 5.14 Mn |
| Dec 31, 2019 | 5.03 Mn |
| Jun 30, 2019 | 4.14 Mn |